From: Multicenter phase II study of matured dendritic cells pulsed with melanoma cell line lysates in patients with advanced melanoma
Response
N
%
Number of patients
33
100%
Number of patients with:
CR
1
3%
PR
2
6%
SD > 8 weeks
6
18%
SD ≤ 8 weeks
9
27%
PD
15
45%
Tumor Growth Control (90% CI)
27% (13% - 46%)
Overall Response Rate (90% CI)
3
9% (3% - 22%)